Hartford Investment Management CO Exelixis, Inc. Transaction History

Hartford Investment Management CO

  • $2.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 29, 2019
SELL
$19.6 - $24.76 $260,248 - $328,763
-13,278 Closed
0 $0
Q3 2018

Nov 08, 2018
SELL
$15.87 - $22.4 $14,060 - $19,846
-886 Reduced 6.26%
13,278 $235,000
Q2 2018

Jul 19, 2018
BUY
$18.56 - $22.45 $262,883 - $317,981
14,164 New
14,164 $305,000

Others Institutions Holding EXEL

# of Institutions
501
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email